Hangzhou Zhongtai Cryogenic Technology Corporation (SHE:300435)
China · Delayed Price · Currency is CNY 23.10
+0.15 (0.65%)
May 8, 2026, 3:04 PM CST
SHE:300435 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 2,588 | 2,741 | 2,708 | 3,042 | 3,251 | 2,398 |
Other Revenue | 9.54 | 9.54 | 8.32 | 5.08 | 5.69 | 9.46 |
| 2,598 | 2,751 | 2,717 | 3,047 | 3,256 | 2,407 | |
Revenue Growth (YoY) | -0.80% | 1.26% | -10.86% | -6.42% | 35.29% | 21.72% |
Cost of Revenue | 1,857 | 1,934 | 2,207 | 2,459 | 2,703 | 1,951 |
Gross Profit | 741.04 | 816.94 | 510.07 | 588.92 | 553.59 | 456.18 |
Selling, General & Admin | 156.75 | 184.93 | 150.24 | 151.64 | 140.62 | 128.31 |
Research & Development | 66.77 | 70.6 | 56.45 | 64.13 | 59.82 | 40.38 |
Other Operating Expenses | 9.56 | 9.39 | 10.51 | 12.71 | 12.88 | 8.7 |
Operating Expenses | 275.4 | 289.35 | 247.93 | 211.49 | 247.77 | 203.47 |
Operating Income | 465.65 | 527.59 | 262.14 | 377.43 | 305.83 | 252.71 |
Interest Expense | -2.63 | -2.82 | -15.78 | -30.51 | -21.61 | -12.25 |
Interest & Investment Income | 13.47 | 16.12 | 45.35 | 57.38 | 47.9 | 33.38 |
Currency Exchange Gain (Loss) | 0.47 | 0.47 | 0.08 | -1.48 | 1.65 | 1.76 |
Other Non Operating Income (Expenses) | -7.4 | -0.95 | -1.16 | -0.42 | -0.59 | 17.82 |
EBT Excluding Unusual Items | 469.55 | 540.4 | 290.64 | 402.39 | 333.18 | 293.43 |
Impairment of Goodwill | - | - | -324.18 | - | - | - |
Gain (Loss) on Sale of Investments | 6.78 | 1.76 | 1.65 | 0.33 | -0.42 | 0.64 |
Gain (Loss) on Sale of Assets | 2.08 | 1.43 | 0.37 | 7.14 | -0.04 | 0 |
Asset Writedown | -1.74 | -0.83 | -2.56 | -0.8 | -0.64 | -0.03 |
Other Unusual Items | 8.5 | 6.98 | 11.66 | 22.29 | 17.48 | 11.9 |
Pretax Income | 489.44 | 554.01 | -22.42 | 431.36 | 355.08 | 311.06 |
Income Tax Expense | 93.55 | 101.05 | 59.8 | 82.13 | 78.07 | 65.54 |
Earnings From Continuing Operations | 395.89 | 452.96 | -82.21 | 349.23 | 277.01 | 245.53 |
Minority Interest in Earnings | -3.21 | -2.6 | 4.25 | 0.83 | 0.95 | -0.17 |
Net Income | 392.68 | 450.36 | -77.96 | 350.06 | 277.96 | 245.35 |
Net Income to Common | 392.68 | 450.36 | -77.96 | 350.06 | 277.96 | 245.35 |
Net Income Growth | - | - | - | 25.94% | 13.29% | 25.11% |
Shares Outstanding (Basic) | 385 | 385 | 390 | 381 | 381 | 377 |
Shares Outstanding (Diluted) | 385 | 385 | 390 | 385 | 381 | 377 |
Shares Change (YoY) | -0.89% | -1.25% | 1.33% | 1.03% | 0.87% | 0.09% |
EPS (Basic) | 1.02 | 1.17 | -0.20 | 0.92 | 0.73 | 0.65 |
EPS (Diluted) | 1.02 | 1.17 | -0.20 | 0.91 | 0.73 | 0.65 |
EPS Growth | - | - | - | 24.66% | 12.31% | 25.00% |
Free Cash Flow | 335.29 | 445.44 | 248.31 | 138 | 27.49 | 101.07 |
Free Cash Flow Per Share | 0.87 | 1.16 | 0.64 | 0.36 | 0.07 | 0.27 |
Dividend Per Share | 0.250 | 0.250 | 0.200 | 0.150 | 0.100 | 0.080 |
Dividend Growth | 25.00% | 25.00% | 33.33% | 50.00% | 25.00% | - |
Gross Margin | 28.53% | 29.70% | 18.78% | 19.32% | 17.00% | 18.95% |
Operating Margin | 17.93% | 19.18% | 9.65% | 12.38% | 9.39% | 10.50% |
Profit Margin | 15.12% | 16.37% | -2.87% | 11.49% | 8.54% | 10.19% |
Free Cash Flow Margin | 12.91% | 16.19% | 9.14% | 4.53% | 0.84% | 4.20% |
EBITDA | 586.07 | 647.91 | 382.08 | 477.74 | 390.14 | 332.11 |
EBITDA Margin | 22.56% | 23.55% | 14.06% | 15.68% | 11.98% | 13.80% |
D&A For EBITDA | 120.42 | 120.32 | 119.94 | 100.31 | 84.31 | 79.4 |
EBIT | 465.65 | 527.59 | 262.14 | 377.43 | 305.83 | 252.71 |
EBIT Margin | 17.93% | 19.18% | 9.65% | 12.38% | 9.39% | 10.50% |
Effective Tax Rate | 19.11% | 18.24% | - | 19.04% | 21.99% | 21.07% |
Revenue as Reported | 2,598 | 2,751 | 2,717 | 3,047 | 3,256 | 2,407 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.